Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 12:11:42.
doi: 10.1186/1471-2350-11-42.

Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY)

Affiliations

Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY)

Trine W Boesgaard et al. BMC Med Genet. .

Abstract

Background: Insulin gene (INS) mutations have recently been described as a common cause of permanent neonatal diabetes (PNDM) and a rare cause of diabetes diagnosed in childhood or adulthood.

Methods: INS was sequenced in 116 maturity-onset diabetes of the young (MODYX) patients (n = 48 Danish and n = 68 Czech), 83 patients with gestational diabetes mellitus (GDM), 34 type 1 diabetic patients screened negative for glutamic acid decarboxylase (GAD), and 96 glucose tolerant individuals. The control group was randomly selected from the population-based sampled Inter99 study.

Results: One novel heterozygous mutation c.17G>A, R6H, was identified in the pre-proinsulin gene (INS) in a Danish MODYX family. The proband was diagnosed at 20 years of age with mild diabetes and treated with diet and oral hypoglycaemic agent. Two other family members who carried the INS R6H were diagnosed with diabetes when 51 years old and with GDM when 27 years old, respectively. A fourth mutation carrier had normal glucose tolerance when 20 years old. Two carriers of INS R6H were also examined twice with an oral glucose tolerance test (OGTT) with 5 years interval. They both had a approximately 30% reduction in beta-cell function measured as insulinogenic index. In a Czech MODYX family a previously described R46Q mutation was found. The proband was diagnosed at 13 years of age and had been treated with insulin since onset of diabetes. Her mother and grandmother were diagnosed at 14 and 35 years of age, respectively, and were treated with oral hypoglycaemic agents and/or insulin.

Conclusion: Mutations in INS can be a rare cause of MODY and we conclude that screening for mutations in INS should be recommended in MODYX patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Segregation of INS R6H (Figure 1A) and R46Q (Figure 1B) mutations in two MODY families. Symbols denote the following: square, male; circle, female; empty symbol, normal glucose tolerant subject; filled symbol, diabetic person; quarter filled, impaired glucose tolerance status/gestational diabetes; symbol with arrowhead, proband. The text, under each individual represents the following: Subject id; age at examination (age at diagnosis); BMI (kg/m2); NGT, normal glucose tolerance; IGT, impaired glucose tolerance; GDM, gestational diabetes mellitus; DM, diabetes mellitus; treatment and mutation status; AAO, age of onset.

Similar articles

Cited by

References

    1. Bonfanti R, Colombo C, Nocerino V. et al.Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies. Diabetes care. 2009;11:123–125. doi: 10.2337/dc08-0783. - DOI - PMC - PubMed
    1. Colombo C, Porzio O, Liu M. et al.Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest. 2008;11:2148–2156. - PMC - PubMed
    1. Edghill EL, Flanagan SE, Patch AM. et al.Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes. 2008;11:1034–1042. doi: 10.2337/db07-1405. - DOI - PMC - PubMed
    1. Støy J, Edghill EL, Flanagan SE. et al.Insulin gene mutations as a cause of permanent neonatal diabetes. Proceedings of the National Academy of Sciences. 2007;11:15040–15044. doi: 10.1073/pnas.0707291104. - DOI - PMC - PubMed
    1. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;11:200–213. doi: 10.1038/ncpendmet0778. - DOI - PubMed

Publication types